U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07943312) titled 'GA001 Injection in Retinitis Pigmentosa' on Nov. 02.
Brief Summary: This Phase II clinical trial evaluates the safety, tolerability, and efficacy of GA001 Injection in patients with retinitis pigmentosa.
Study Start Date: April 01, 2027
Study Type: INTERVENTIONAL
Condition:
Retinitis Pigmentosa (RP)
Intervention:
GENETIC: GA001
Single unilateral IVT injection of GA001 Injection in the study eye
PROCEDURE: Sham injection
Sham IVT procedure in the study eye
Recruitment Status: NOT_YET_RECRUITING
Sponsor: GenAns Biotechnology Co., Ltd
Published by HT Digital Content Services with permission from Health Daily Digest....